Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Erratum: Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

The Original Article was published on 18 September 2007

This article has been updated

Correction to: British Journal of Cancer (2008) 97, 857–861, doi:10.1038/sj.bjc.6603942

The authors of the above paper, first published in October 2007, would like to add the following acknowledgement to their paper:

We thank Programme Hospitalier de Recherche Clinique (PHRC).

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

Authors

Additional information

The online version of the original article can be found at 10.1038/sj.bjc.6603942

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and Permissions

About this article

Cite this article

Massard, C., Voigt, JJ., Laplanche, A. et al. Erratum: Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?. Br J Cancer 99, 1959 (2008). https://doi.org/10.1038/sj.bjc.6604800

Download citation

Search

Quick links